Vermillion & White Wealth Management Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-950
Closed -$47.2K 350
2025
Q4
$47.2K Buy
950
+200
+27% +$18.8K 0.03% 156
2025
Q3
$62.9K Buy
750
+502
+202% +$41.3K 0.04% 134
2025
Q2
$19.6K Hold
248
0.01% 236
2025
Q1
$22.3K Hold
248
0.02% 186
2024
Q4
$24.7K Hold
248
0.02% 180
2024
Q3
$28.2K Hold
248
0.02% 166
2024
Q2
$30.7K Hold
248
0.02% 161
2024
Q1
$32.7K Hold
248
0.03% 147
2023
Q4
$27K Buy
+248
New +$25.7K 0.03% 127

Other funds holding MRK

Vermillion & White Wealth Management Group's MRK Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of Merck (MRK) in Q1 2026, closing a stake of 950 shares — an estimated $47.2K sold.

Vermillion & White Wealth Management Group first reported a position in MRK in Q4 2023 and held it in 9 quarters. The position peaked at $62.9K in Q3 2025. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Vermillion & White Wealth Management Group reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 950 Merck shares in Q1 2026, an estimated $47.2K.
  • Vermillion & White Wealth Management Group first reported a position in Merck in Q4 2023 and held it in 9 quarters.
  • Vermillion & White Wealth Management Group's Merck position peaked at $62.9K in Q3 2025.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.